LGALS9 and cancer: Using 90 surgically resected specimens, we measured galectin-9 mRNA expression in hepatocarcinoma and adjacent cancer tissue and found significant differences in terms of pathologic differentiation, TNM, and recurrent metastasis (p < 0.05) [135].